Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
Eli Lilly & Co.   (ticker: LLY)
Quote:() Quotes on: Yahoo | Google
5 day's Perf: 100%
1 Month Perf: 100%
3 Month Perf: 100%
YTD Perf: 100%
1 Year Perf: 100%
Stock chart
Useful Quick Links for LLY
Financial Key Date: Yahoo
Option Prices: MarketWatch
Technical Opinion: Barchar.com
Technical Charts: StockCharts.com
Analyst & Estimates: Reuters
Ratings: TheStreet.com
SEC Filings: EDGAR Online
Message Boards: Yahoo | TheLion
Insiders' Indicator :       Strong Sell       (Click Here For Details)
INSIDERS' Score: 10
0 100 10
Latest 1 month: 0 5,000
Latest 6 Months: 0 2,236,222
52 Weeks: 13,405 5,580,949
Gurus' Indicator :       Strong Buy       (Click Here For Details)
GURUS' Score: 95
0 100 95
Current Holdings: 8,057,861
Previous Holdings: 4,883,724
Change: 64.99%
Institutions' Indicator :       Strong Buy       (Click Here For Details)
0 100 80
Current Holdings: 675,113,053
Previous Holdings: 485,664,253
Change: 39.01%
News And Links For The Group (Contribute a link)
[LLY]   Innovent and Lilly Release Biomarker Results of TYVYT« (Sintilimab Injection) in Combination with ALIMTA« (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020  (PR Newswire)   20-Sep-20 20:36
[LLY]   Innovent and Lilly Jointly Release Phase 3 Results of TYVYT« (Sintilimab Injection) in Combination with GEMZAR« (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020  (PR Newswire)   20-Sep-20 20:00
[LLY]   Verzenio« Significantly Reduced the Risk of Cancer Recurrence by 25% for People with HR+, HER2- High Risk Early Breast Cancer  (PR Newswire)   20-Sep-20 14:01
[LLY]   3 Top Biotech Picks for 2025  (Motley Fool)   20-Sep-20 07:32
[LLY]   CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Atopic Dermatitis  (PR Newswire)   18-Sep-20 07:44
[LLY]   Taysha Gene Therapies Seeks $125 Million IPO For Ambitious Pipeline  (Seeking Alpha)   17-Sep-20 15:17
[LLY]   Ampio Pharmaceuticals Is Waking Up From Its COVID-19 Slumber, Approaching Potential Approval For Severe OAK  (Seeking Alpha)   16-Sep-20 15:37
[LLY]   Merger Monday Confirms An Active Stock Market - Buy Under-Appreciated Biotech  (Seeking Alpha)   15-Sep-20 13:15
[LLY]   Virios Therapeutics Seeks IPO For Fibromyalgia Pain Treatment  (Seeking Alpha)   15-Sep-20 07:30
[LLY]   Don't Buy High And Sell Low: What Today's Investors Can Learn From The 'Nifty Fifty'  (Seeking Alpha)   3-Sep-20 12:01
[LLY]   Retirement: 10 Recession-Proof DGI Stocks (Almost)  (Seeking Alpha)   29-Aug-20 09:44
[LLY]   Jardiance« reduced the combined relative risk of cardiovascular death and hospitalization for heart failure by 25% in adults with and without diabetes who had heart failure with reduced ejection fraction  (PR Newswire)   29-Aug-20 06:00
[LLY]   Nektar Looks Undervalued, But The Biggest Value-Driving Events Are Still In 2021  (Seeking Alpha)   28-Aug-20 16:00
[LLY]   COVID-19 Treatments: Remdesivir Disappoints, Antiviral SPL7013 And Monoclonal Antibodies Interesting For Prevention/Early-Stage Treatment  (Seeking Alpha)   27-Aug-20 14:09
[LLY]   New England Journal of Medicine Publishes Phase 1/2 Data for Retevmo? (selpercatinib) in Advanced RET-Driven Lung and Thyroid Cancers  (PR Newswire)   27-Aug-20 06:45
[LLY]   XLV: The Healthcare Sector Is Underestimated  (Seeking Alpha)   25-Aug-20 16:31
[LLY]   Week In Review: Innovent Out-Licenses Ex-China Rights For PD-1 To Lilly In $1 Billion Deal  (Seeking Alpha)   23-Aug-20 08:36
[LLY]   IPO Update: Kymera Therapeutics Readies $125 Million IPO  (Seeking Alpha)   17-Aug-20 19:02
[LLY]   Novo Nordisk: Long-Term Growth By CV Risk Factor Reduction  (Seeking Alpha)   17-Aug-20 08:26
[LLY]   Biotech's Q2:┬á Lots Of Candidates That May Deliver Alpha  (Seeking Alpha)   9-Aug-20 12:29
==>More News
*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*